InvestorsHub Logo

JPG77

04/22/20 6:29 PM

#70284 RE: TheBioTechG #70192

The mainstream media is hyping a “study” with data culled from Veterans Health Administration hospitals to justify their attack on Hydroxychloroquine, an anti-malaria drug that President Donald Trump is fighting to provide to suffering people. ABC White House correspondent Jon Karl agitated against Hydroxychloroquine in Trump’s Tuesday White House Task Force briefing, citing this VA study. FDA commissioner Stephen Hahn said “This study is a small retrospective study at the VA” and stressed that results of clinical trials, in progress, are needed.

The study cannot be used to credibly attack Hydroxychloroquine because the drug was given to sicker veterans more likely to die anyway as opposed to healthier people. The study was posted on the Internet but not reviewed by other scientists. The study claims 22 percent of people given Hydroxychloroquine plus azithromycin died, whereas only 11 percent died with regular care, but the study even notes that there’s no way to discount other factors contributing to the deaths of patients given Hydroxychloroquine plus azithromycin. One of the authors of the study has a patent application pertaining to Coronavirus and another author took a research grant from Gilead, which is developing a competitor drug to Hydroxychloroquine (the study claimed these competing interests were unrelated to the study itself).

Still crazy that people refuse to accept the importance of evidence-based medicine.



Yeah, amazing how some people quickly jump to assumptions and refuse to accept commonly used medicine by quoting a small and questionable study.